Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study

BACKGROUND AND OBJECTIVE: Experience of the use of lenvatinib (LEN) in the clinical setting remains limited. We conducted this study to elucidate the factors associated with progression-free survival (PFS) in patients with advanced HCC treated with LEN. METHODS: In this multicenter retrospective stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohki, Takamasa, Sato, Koki, Kondo, Mayuko, Goto, Eriko, Sato, Takahisa, Kondo, Yuji, Akamatsu, Masatoshi, Sato, Shinpei, Yoshida, Hideo, Koike, Yukihiro, Obi, Shuntaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221074/
https://www.ncbi.nlm.nih.gov/pubmed/32048238
http://dx.doi.org/10.1007/s40801-020-00179-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221074/
https://www.ncbi.nlm.nih.gov/pubmed/32048238
http://dx.doi.org/10.1007/s40801-020-00179-7

Ejemplares similares